Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Recombinant Cynomolgus/Rhesus EDAR Fc Chimera Protein
Click to view available options
Quantity:
50 μg
Description
Measured by its binding ability in a functional ELISA. When Recombinant Human EDA-A1/Ectodysplasin A1 Protein (Catalog # 3944-ED ) is immobilized at 1.00 μg/mL (100 μL/well), the concentration of Recombinant Cynomolgus Monkey/Rhesus Macaque EDAR Fc Chimera (Catalog # 10968-ER) that produces 50% of the optimal binding response is 1.50-15.0 ng/mL.
Specifications
Specifications
Accession Number | XP_005575284.1 |
For Use With (Application) | Bioactivity |
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Gene ID (Entrez) | 10913 |
Molecular Weight (g/mol) | M.W.-observed: 53-65 kDa, under reducing conditions., M.W.-theroretical: 44 kDa |
Quantity | 50 μg |
Source | Chinese Hamster Ovary cell line, CHO-derived EDAR protein Cynomolgus Monkey/Rhesus Macaque EDAR (Glu27-Ala187) (N-terminus) Accession # XP_005575284.1 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus) |
Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
Endotoxin Concentration | <0.10 EU / 1 μg of the protein by the LAL method. |
Gene Alias | Anhidrotic ectodysplasin receptor 1, DLED3, Ectodermal dysplasia receptor, ectodysplasin 1, anhidrotic receptor, ectodysplasin A receptor, Ectodysplasin-A receptor, ED1R, ED5, EDA1R, EDA3EDA-A1 receptor, EDA-A1R, Edar, FLJ94390, HRM1, mouse, homolog of, tumor necrosis factor receptor superfamily member EDAR |
Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction